Thursday, January 4, 2018

DermTech Gets Approval In Canada

La Jolla-based molecular dermatology treatment developer DermTech announced this morning that its Canadian subsidiary, DermTech Canada, has received approval from Health Canada to market its Pigmented Lesions Assay (PLA) and non-invasive biopsy kit for the detection of melanoma in Canada. DermTech said it will process samples at DermTech's laboratory in La Jolla. DermTech said it will initially make the tests available in British Columbia and Ontario.